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The Bcl-2 associated athanogene 1M (Bag-1M) is known to repress the transactivation of the gluco-
corticoid receptor (GR). We report here that Bag-1M inhibits the action of GR via recruitment of
corepressors, including nuclear receptor corepressor (NcoR) and silencing mediator for retinoic acid
and thyroid hormone receptor (SMRT), and histone deacetylase (HDAC)3 to the genomic response
element of a glucocorticoid-regulated human metallothionein IIa (hMTIIa) gene. A mutant GR lack-
ing the interaction with BAG-1M fails to recruit the corepressors NcoR and SMRT. RNAi-mediated
knock down of corepressors and the use of HDAC inhibitor relieved Bag-1M-induced repression
on the transactivation of the GR. In addition, Bag-1M is not involved in the degradation of the recep-
tor. These ﬁndings indicate a novel mechanism by which Bag-1M acts as a corepressor and downreg-
ulates the activity of the GR.
Structured summary:
MINT-7216164: HDAC3 (uniprotkb:O15379) physically interacts (MI:0914) with Bag1 (uniprotkb:Q99933)
by anti bait coimmunoprecipitation (MI:0006)
MINT-7216183: NCOR (uniprotkb:O75376) physically interacts (MI:0914) with Bag1 (uniprotkb:Q99933)
by anti bait coimmunoprecipitation (MI:0006)
MINT-7216175: SMRT (uniprotkb:Q9Y618) physically interacts (MI:0914) with Bag1 (uniprotkb:Q99933)
by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Bcl-2 associated athanogene 1 (Bag-1) proteins are cochap-
erones that are involved in the regulation of nuclear receptor
action [1–5]. In human, the Bag-1 gene encodes four isoforms of
the Bag-1 proteins (Bag-1L, Bag-1M, Bag-1S and p29), all of which
are expressed through alternative translation initiation sites from
the same mRNA [6]. Although it was initially identiﬁed as a Bcl-2
binding protein to suppress apoptosis [7], Bag-1 has been known
to interact with and regulate the activity of other proteins. Forchemical Societies. Published by E
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ong), aban@mti.uni-jena.deexample, Bag-1 interacts with and inhibits the function of the tu-
mor suppressor p73 [8]. Furthermore, the medium isoform, Bag-
1M is increased in the hippocampus of Alzheimer’s disease pa-
tients and binds to Tau protein and amyloid precursor protein
(APP), and overexpressed Bag-1M induces increased level of Tau
and APP that are related with the pathology and treatment of Alz-
heimer disease [9,10].
The different Bag-1 proteins exert varying effects on the trans-
activation function of nuclear receptors. The largest isoform, Bag-
1L, enhances the transactivation of androgen receptor (AR) [11]
but inhibits the action of glucocorticoid receptor (GR) [12],
whereas, Bag-1M, downregulates the transactivation of GR [13].
Recent study revealed that Bag-1M localized to the glucocorticoid
response element (GRE) in a hormone sensitive manner and re-
pressed the DNA binding by the GR [14]. This provides another evi-
dence that molecular chaperones and cochaperones can modulate
the nuclear receptor action at the genomic response element apart
from the previous ﬁnding that molecular chaperone p23 was pres-
ent at the response element in the presence of hormone and dis-
rupted receptor-mediated transcriptional activation [15].lsevier B.V. All rights reserved.
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the GR through its ubiquitin like domain that is involved in the
degradation of GR in a hormone dependent manner in the presence
of another cochaperone chromatin C-terminus of heat shock pro-
tein (Hsp) 70 interacting protein (CHIP) [16].
Glucocorticoid regulates the expression of target genes involved
in many pathophysiological processes. A human methallothionein
IIa (hMTIIa) gene has been identiﬁed and used as a model to inves-
tigate the action of GR [17]. Although heavy metal cations are the
most potent inducers of MT in mammals, other agents also initiate
increases in MT expression [18]. For example, glucocorticoid trans-
activates the expression of hMTIIa gene through the GR that binds
to the GRE located upstream of the gene [17].
Here, we report that Bag-1M is not involved in the degradation
of GR through the ubiquitin–proteosome pathway as a potential
mechanism for down-regulation of GR activity. Rather, our data
suggest that Bag-1M recruits corepressors and histone deacetylase
(HDAC), in a hormone dependent manner, to the GR genomic
response element of the hMTIIa gene. In line with this, knock-down
of corepressors and inhibition of HDAC activity reversed Bag-1M-
mediated negative effect.2. Materials and methods
2.1. Cell culture
COS-7 and HeLa cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM), supplemented with 10% fetal calf serum
at 37 C and in an atmosphere of 5% CO2. All culture media con-
tained 100 units/ml penicillin and 100 lg/ml streptomycin.
2.2. Plasmid constructs
The plasmids expressing the wild-type human GR, the mutant
GR, Bag-1M, the indicator plasmid pGL3MMTV, control plasmid
pRenilla-luc and the hMTIIa reporter plasmid H1S CAT have previ-
ously been reported [14]. pEGFP-C2 was commercial available
from Clontech, Palo Alto, CA.
2.3. Antibodies
For ChIP assay, GR (P-20), Bag-1 (FL-274), nuclear receptor core-
pressor (NcoR) (H-303), silencing mediator for retinoic acid and
thyroid hormone receptor (SMRT) (C-19) and HDAC3 (H-99) anti-
bodies and rabbit IgG and goat IgG (all from Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) were used. The following antibodies were used
for immunoprecipitation: Bag-1 (FL-274), NcoR (H-303), SMRT (C-
19), HDAC3 (H-99), all from Santa Cruz. For immunoblot (IB), Bag-1
(C-16, Santa Cruz), Actin (I-19, Santa Cruz), SMRT (N-20, Santa
Cruz) and NcoR (06-892, Upstate) antibodies were employed.
2.4. Transfection assay and luciferase reporter gene assay
COS-7 cells were transiently transfected with plasmid con-
structs using Fugene 6 reagent (Roche Diagnostics, Basel, Swit-
zerland) according to the manufacturer’s instructions. The
efﬁciency of transfection was determined as the percentage of
green ﬂuorescent cells following cotransfection of pEGFP-C2, a
mammalian expression plasmid encoding for enhanced green
ﬂuorescent protein. It remained stable throughout the reported
experiments at a level of 75–80%. The reporter gene assay has
previously been described [14]. In this assay, three independent
experiments were performed and the data were analyzed, by a
software for the student’s t-test, to calculate the probability va-
lue (P-value) to check, whether or not, a signiﬁcant differenceexists between two groups of data obtained under conditions
of different treatments.
2.5. Immunoprecipitation and IB
The transiently transfected and dexamethasone treated COS-7
cells were further treated with 1 mM dimethyl 3,30-dithiobispropi-
onimidate (Pierce Biotechnology, Rockford, IL) for 30 min to cross-
link the protein. Cells were lysed in buffer (0.5% NP-40, 20 mM Tris,
pH 8.0, 100 mM NaCl, 1 mM EDTA, 10% glycerol) and preincubated
with protein A sepharose (Amersham Bioscience, Shanghai, China).
Bag-1, NcoR, SMRT or HDAC3 antibodies were used for immuno-
precipitation and IB was followed with Bag-1 antibody.
2.6. ChIP and re-ChIP
ChIP and re-ChIP were performed as previously described [19].
For ChIP in transfected COS-7 cells, 10% of the precleared superna-
tant was taken out as input. The PCR reactions of input and immu-
noprecipitated material were run with 28 cycles. The primers used
for the PCR ampliﬁcation are (in 50–30 direction): CCG GTT ACT GTG
ATG CTG CA (hMTIIa for), GCG GGA GGA CAC AGT GTA CC (hMTIIa
rev). For Re-ChIP, 20% of the elute after the ﬁrst precipitation but
before the second precipitation was obtained as input. The PCR
reactions of input and immunoprecipitated material were run with
32 cycles. For ChIP in HeLa cells, 20% of the precleared supernatant
was used as input and the PCR reactions were run with 28 cycles.
2.7. RNA interference
NcoR small interfering RNA (siRNA) (M-003518-01), SMRT siR-
NA (M-020145-02) and the luciferase GL3 siRNA used as control,
were all purchased from Dharmacon. Transfection of COS-7 and
HeLa cells with the siRNA was performed using an Oligofectamine
reagent (Invitrogen, Shanghai, China) at a ﬁnal concentration of
150 nM. The cells were ﬁnally collected for measurement of lucif-
erase activity, real-time PCR and immunoblot.
2.8. Real-time PCR
The primers (in 50–30 direction): TCG GAT ACG TCA TCA GCA CC
(for) and TCC CTC CTG TCC TGT ACT CGA (rev) were used for the
detection of hMTIIa gene expression. Human b-actin gene expres-
sion was detected as a control by the primers: TCA CCC ACA CTG
TGC CCA T (for) and CTC TTG CTC GAA GTC CAG GG (rev). The
ABI PRISM 7000 sequence detection system and the SYBR Green
PCR Master Mix (Applied Biosystem, Shanghai, China) and 40
cycles were used for the ampliﬁcation. Three independent real-
time PCRs were run and the data were analyzed, by a software
for the Student’s t-test, to calculate the P-value to check, whether
or not, a signiﬁcant difference exists between two groups of data
obtained under conditions of different treatments.3. Results and discussion
3.1. Bag-1M recruits corepressors and HDAC
Since we have previously shown that Bag-1M and GR are pres-
ent at the GRE of a glucocorticoid-regulated human metallothio-
nein IIa (hMTIIa) gene [14], it is worthwhile to investigate how
Bag-1M alters the action of the GR complex at the GRE. ChIP was
therefore carried out to identify the possible factors that are in-
volved in the GR complex. COS-7 cells that are devoid of GR and
Bag-1M [12] were transfected with an hMTIIa reporter gene. In
addition, Bag-1M, the wild-type GR or a mutant GR (glucocorticoid
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with Bag-1M but mediates hormone response [21], were cotrans-
fected with the reporter plasmid. No protein was found to bind
the GRE of the hMTIIa gene, in the absence of hormone but in
the presence of Bag-1M, as shown by no detectable ampliﬁed
DNA fragment (Fig. 1A). When the cells were only transfected with
either the wild-type GR or the mutant GR, the receptors were pres-
ent at the GRE after hormone treatment (Fig. 1A). In the cells
cotransfected with vectors coding for Bag-1M and GR, both factors
bind to the GRE in the presence of hormone (Fig. 1A). Intriguingly,
the presence of Bag-1M and the wide type GR at the GRE lead to
the recruitment of the endogenously expressed corepressors,
including NcoR and SMRT, as well as histone deacetylase3
(HDAC3). However, in the cells cotransfected with Bag-1M and
GRmt, only GRmt was present at the GRE, indicating Bag-1M is re-
cruited to the response element by interacting with speciﬁc amino
acid sequences of the GR (Fig. 1A), and suggests that NcoR, SMRT
and HDAC3 require BAG-1M for recruitment to GR.
To demonstrate that the GR, Bag-1M, corepressors and HDAC3
are all present at the same promoter, a re-ChIP analysis was per-
formed for which the anti-Bag-1 antibody was employed for the
ﬁrst immunoprecipitation and resulted in a PCR product in the
presence of hormone (Fig. 1B). The second immunoprecipitation
of the Bag-1 ﬁrst immunoprecipitate using the GR, NcoR, SMRT
and HDAC3 antibodies revealed a PCR product of the same genomic
locus (Fig. 1B). Control experiment showed that the Bag-1 antibody
was completely inactivated before the use of the second set of anti-
bodies (Fig. 1B) and no unspeciﬁc immunoprecipitation was
occurred by IgG (Fig. 1B). These data further conﬁrm that Bag-
1M recruits corepressors and HDAC to the GRE. We assume that
the effect of Bag-1M may be due to its ability to interact with
the corepressors and HDAC. Accordingly, we carried out the immu-
noprecipitation experiments and could show that NcoR and Bag-1
antibodies could immunoprecipitated Bag-1M (Fig. 1C). Accord-
ingly, SMRT and Bag-1 speciﬁc antibodies could also immunopre-
cipitate Bag-1M (Fig. 1D). The use of HDAC3 and Bag-1
antibodies immunoprecipitate Bag-1M as well (Fig. 1E), but Bag-
1M could not be immunoprecipitated by the control IgG as shown
in the IBs (Fig. 1C–E). The data suggest that BAG-1M is complexed
with SMRT, NcoR and HDAC3 on chromatin.rIgG
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Fig. 1. Corepressors and histone deacetylase are recruited by Bag-1M to the GR target ge
the wild-type GR but not the mutant GR (GRmt, K496L/I497G). COS-7 cells were transi
vectors encoding either the wild-type GR or GRmt, together with or without an expressio
dexamethasone (107 M) or ethanol for 1 h and were analysed for factor occupancy at th
hMTIIa gene promoter in transfected COS-7 cells with the anti-Bag-1 antibody for the
immunoprecipitation with antibodies against GR, Bag-1, NcoR, SMRT and HDAC3, respec
inputs. (C–E) An aliquot from the ChIP assay was applied for immunoprecipitation with an
was performed with anti-Bag-1M antibody and IgG as a control.While Bag-1M appears to be recruited to GRE through interac-
tion with distinct amino acid sequences of the GR, the exact se-
quence requirements for interacting with GR need to be further
identiﬁed. Several corepressor complexes associated with nuclear
receptors have been elucidated, among which the NcoR–SMRT
complex harboring HDACs is the most notable one [20]. Bag-1M
interacts with NcoR and SMRT which in turn to bind the HDAC
and this may explain how these proteins are recruited to the
GRE. Our previous ﬁnding revealed that Bag-1M inhibits the DNA
binding by the GR [14]. Thus, there might be two mechanisms uti-
lized by Bag-1M to downregulate the transactivation of GR. One is
to reduce the DNA binding by the GR and the other is to recruit
corepressors to the response element. Reduced DNA binding by
the GR was mostly seen in vitro indicating that on chromatin level,
the reduced GR binding plays a subordinated role in attenuating
the action of GR.
3.2. Corepressors and HDAC are essential for Bag-1M-mediated
inhibition of the transactivation of the GR
To further conﬁrm whether corepressors and HDAC are in-
volved in the repression of the GR activity by Bag-1M, siRNA
was employed to knock down corepressors NcoR and SMRT. In
the cells cotransfected with GR and Bag-1M, Bag-1M represses
the action of GR in a hormone-dependent manner (Fig. 2A, com-
pare the value of lane 2 with that of lane 4, statistical analysis
showed P < 0.05), and Bag-1M-mediated repression on the trans-
activation of the GR was not altered when control siRNA was
introduced into the cells (Fig. 2A, compare lane 4 with lane 8,
P > 0.05). In contrast, when siRNA of NcoR or SMRT was transfec-
ted to the cells, respectively, Bag-1M-induced inhibition on the
transactivation of the GR was partially released and cotransfec-
tion of the NcoR and SMRT siRNAs had a synergic effect, suggest-
ing that NcoR and SMRT are involved in Bag-1M-mediated
negative regulation on the action of GR (Fig. 2A, compare lanes
12, 16 and 20 with lane 8, the respective P < 0.05). None of
the transfected siRNAs affected the ligand-dependent transacti-
vation of the GR (Fig. 2A, compare lanes 6, 10, 14 and 18 with
lane 2, the respective P > 0.05). In addition, no signiﬁcant differ-
ences could be found among the basal levels of transactivationrIg
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Fig. 2. Corepressors and histone deacetylase are essential for Bag-1M-mediated negative effect. (A) COS-7 cells were transiently transfected with a luciferase reporter gene,
vectors encoding GR and Bag-1M. Twenty-four hours after transfection, the cells were transfected with siRNA of NcoR. Twenty-four hours after the transfection of siRNA, the
cells were treated with dexamethasone (107 M) or ethanol for 16 h before they were harvested for the measurement of luciferase activity. The bar charts represent the mean
and standard deviation of three independent experiments. (B and C) Aliquots of the transfected cells were applied for immunoblots with the anti-NcoR, anti-SMRT and anti-
actin antibodies. Shown is the protein level of NcoR and SMRT. (D) Effect of trichostatin A (TSA) on Bag-1M-mediated repression of glucocorticoid receptor activity. COS-7
cells were transfected as indicated in (A). Twenty-four hours after transfection, the cells were treated with dexamethasone (107 M) or ethanol together with or without TSA
for 16 h. Then the cells were prepared for luciferase assay. The bar charts represent the mean and standard deviation of three independent experiments.
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the respective P > 0.05). IBs showed that the protein level of
NcoR and SMRT was effectively knocked down, respectively, by
siRNA compared with those from the non-transfected or control
siRNA transfected cells (Fig. 2B and C).
Since HDAC3 was also found to be present at the GRE of the
glucocorticoid-regulated gene, we used trichostatin A (TSA), an
HDAC inhibitor, to inhibit the activity of HDAC to investigate
the expression of the reporter gene. As previously shown, Bag-
1M inhibits the transactivation of the GR, but its negative effect
was largely reversed by the use of TSA, which did not affect the
transactivation mediated by the GR (Fig. 2D, compare lane 4
with lane 8, P < 0.05; compare lane 2 with lane 6, P > 0.05). How-
ever, there were no signiﬁcant differences among the basal level
transactivations (Fig. 2D, when any two of the basal level values
were compared, the respective P > 0.05). This conﬁrmed that
Bag-1M recruits corepressors that subsequently interact with
HDAC to suppress the expression of the glucocorticoid-induced
reporter gene.
To further conﬁrm, whether or not, the recruitment of corepres-
sors and HDAC3 is due to the overexpressed Bag-1M in the trans-
fection experiments, ChIP assays were carried out in which thebinding of the GR to genomic GRE of the hMTIIa gene in HeLa cells
was analyzed. In the absence of dexamethasone, we did not detect
factors binding to the GRE (Fig. 3A). In contrast, GR, Bag-1M, NcoR,
SMRT and HDAC3 were all present at the response element in a li-
gand-dependent manner (Fig. 3B). To characterize the effect of
corepressors on GR action, we made use of HeLa cells in which
the endogenous level of NcoR and SMRT has been knocked down
by transfection of siRNA to investigate the expression of the hMTIIa
gene. As shown in Fig. 3C, dexamethasone treatment induced the
expression of the hMTIIa gene and transfection of siRNAs did not
affect the basal level expression of the gene (Fig. 3C, compare lanes
2–5 with lane 1, the respective P > 0.05). Also, transfection of con-
trol siRNA had no effect on the expression of the hMTIIa gene
(Fig. 3C, compare lane 7 with lane 6, P > 0.05). In contrast, transfec-
tion of either NcoR or SMRT siRNA, or a cotransfection of NcoR and
SMRT siRNAs, led to increased expression of the hMTIIa gene
(Fig. 3C, compare lanes 8–10 with lane 7, the respective P < 0.05),
indicating these corepressors are involved in the downregulation
of the activity of the GR by the endogenous Bag-1M. The endoge-
nous level of NcoR and SMRT was effectively knocked down by siR-
NA, as shown by the IBs, compared with those from the non-
transfected or control siRNA transfected cells (Fig. 3D and E).
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Fig. 3. NcoR, SMRT and HDAC3 are needed by Bag-1M to repress the transcription
of glucocorticoid responsive gene. (A and B) ChIP experiments were performed with
HeLa cells to detect the recruitment of endogenously expressed GR, NcoR, SMRT and
HDAC3 in the absence (A) or presence (B) of GR agonist. (C) Transfection of NcoR
and SMRT siRNAs enhances the expression of hMTIIa in HeLa cells. HeLa cells
transfected with control, NcoR or/and SMRT siRNA for 48 h were additionally
treated with dexamethasone (107 M) or ethanol for 16 h. Total RNA was isolated
and used for analysis of hMTIIa expression by real-time PCR. (D and E) Aliquots of
the cells transfected with siRNA were used for immunoblots with anti-NcoR, anti-
SMRT and anti-actin antibodies. Shown is the protein level of NcoR and SMRT. (F)
HeLa cells were treated with dexamethasone (107 M) or ethanol together with or
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the hMTIIa expression. The bar charts represent the mean and standard deviation of
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Fig. 4. Bag-1M did not target GR for degradation. COS-7 cells were transfected with
vectors encoding GR and Bag-1M, together with a vector encoding Renilla luciferase
as internal control. Forty-eight hours after transfection, the cells were treated with
MG132 (106 M) or dimethyl sulfoxide (vehicle), 1 h later, the cells also received
treatment of dexamethasone (107 M) or ethanol for 16 h. Whole cell lysates were
prepared to measure Renilla luciferase activity for transfection efﬁciency and to
carry out immunoblots with anti-GR, anti-Bag-1M and anti-actin antibodies.
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hMTIIa promoter results in negative regulation of the activity of
GR, we treated HeLa cells with TSA in the absence or presence of
glucocorticoid. RNA was isolated and analyzed by real-time PCR
to determine the level of transcription of the hMTIIa gene. As
shown in Fig. 3F, TSA treatment enhanced the ligand-sensitive
transcription (Fig. 3F, compare lane 4 with lane 3, P < 0.05), but
did not alter the basal transcription of the hMTIIa gene (Fig. 3F,
compare lane 2 with lane 1, P > 0.05).
Taken together, Bag-1M appears to act as a corepressor when
tethered to GREs by recruiting multiple factors that function to in-
hibit ligand-dependent transactivation by the GR. RNAi-mediated
ablation of corepressors in COS cells with transfected reporter gene
relieved the repression of GR by Bag-1M. In agreement with this
ﬁnding, transfection of siRNA of corepressors into HeLa cells con-
taining endogenous GR and Bag-1M enhanced the transcriptionof the genomically encoded GR-regulated gene, conﬁrming the
importance of corepressor recruitment for the inhibitory activity
of Bag-1M. NcoR and SMRT are potent corepressors that are pres-
ent in protein complexes containing HDACs and their corepressor
activity is mediated through HDAC-dependent mechanism.
Accordingly, the HDAC inhibitor TSA largely relieved the repression
of GR by Bag-1M as demonstrated from the transfected indicator
gene as well as the endogenous glucocorticoid responsive gene,
suggesting that the negative activity of Bag-1M is, at least in part,
HDAC-dependent.
3.3. Bag-1M is not involved in the degradation of GR
Since Bag-1M contains a ubiquitin-like domain, we investigated
whether Bag-1M-mediated downregulation of the action of the GR
is due to its involvement in the ubiquitin–proteosome pathway for
receptor degradation. Therefore, COS-7 cells were cotransfected
with vectors coding for GR and Bag-1M. In addition, the transfected
cells were treated with a proteosome inhibitor MG132 and then
were lysed for IB to determine the receptor level. The data showed
that when MG132 was used to inhibit the proteosome activity, the
receptor level was enhanced implying that under basal condition
the GR was degraded through the proteosome (Fig. 4). While in
the presence of Bag-1M, the receptor levels were not altered in
the absence or presence of MG132 (Fig. 4, compare lanes 7 and 8
with 3 and 4; lanes 9 and 10 with 5 and 6), suggesting that Bag-
1M did not target GR for degradation. Our data is different from
a previous ﬁnding that Bag-1M is involved in the GR degradation
in the presence of another cochaperone CHIP that ubiquitinates
the receptor for subsequent degradation [16].
However, our ﬁnding is consistent with the observation that
several nuclear receptors including GR are ubiquitinated and de-
graded in the course of their nuclear activities [21–26]. In addition
to receptors, studies have revealed that coactivators, including ste-
roid receptor coactivator 1 (SRC1), SRC2, SRC3, CBP and E6-associ-
ated protein (E6-AP), could also be ubiquitinated and degraded,
through the proteosome, in order to disassemble and reassemble
coactivator complexes, thereby promoting enhanced transcription
[27]. It is conceivable that the ubiquitination and degradation of
the p160 coactivators could possibly contributed to a preinitiation
complex, allowing for transcription elongation to proceed. In this
manuscript, we have demonstrated that Bag-1M was not involved
in ubiquitin–proteosome-mediated degradation of the GR, but the
role of Bag-1M in the ubiquitination of the p160 coactivators still
needs to be elucidated.
It has been recognized that molecular chaperones and cochap-
erones exert an important role in the modulation of the action of
nuclear receptors in addition to the formation of a complex to keep
2456 W. Hong et al. / FEBS Letters 583 (2009) 2451–2456the receptors in an appropriate conformation for ligand binding
[28,29]. Recently, heat shock protein 90 (Hsp90) has been reported
to enhance the DNA binding by the liganded vitamin D receptor
and is essential for optimal vitamin D responsiveness [30].
GCUNC45, an Hsp90 cochaperone, effectively blocks the progres-
sion of progesterone receptor chaperoning in the presence of
Hsp90beta [31]. Hsp27 was known to dysregulate the interaction
of estrogen receptor with chromatin and acts as a suppressor of
estrogen-induced transcription [32,33]. Hsp27 was also shown to
be phosphorylated in an androgen-dependent manner and en-
hanced the AR stability, shuttling and transactivation, thereby pro-
moted the survival of prostate cancer cells [34]. In addition, a
histone chaperone termed nucleophosmin (NPM/B23) interacts
with AR to promote AR binding to the androgen response element
and subsequently modulate the transactivation of the AR [35]. In-
deed, our data provide additional evidence to support the notion
that chaperones modulate the activity of nuclear receptors and this
mode of modulation can be fulﬁlled in different manners.
In conclusion, our data suggest that BAG-1M downregulates
GR-mediated transactivation by recruiting the corepressors NcoR,
SMRT and HDAC3 to GR and indicates BAG-1M is a novel corepres-
sor for GR to modulate its agonist-induced transactivation.
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